Elias Dakwar, MD

Dr. Dakwar completed a fellowship in Addiction Psychiatry at Columbia and received a K23 award evaluating the ketamine infusions combined with mindfulness training to treat cocaine use disorders. Most recently, he is a principal investigator on several R01s evaluating ketamine for induction onto extended-release naltrexone for opioid use disorder as well as ketamine infusion to facilitate treatment for cocaine use disorder and alcohol use disorder.